Original Data
Rev Diabet Stud,
2010,
7(1):47-61 |
DOI 10.1900/RDS.2010.7.47 |
Dendritic Cell-Targeted Pancreatic β-Cell Antigen Leads to Conversion of Self-Reactive CD4+ T Cells Into Regulatory T Cells and Promotes Immunotolerance in NOD Mice
Cathleen Petzold1,2, Julia Riewaldt1,2, Tina Koenig1, Sonja Schallenberg1, Karsten Kretschmer1
1Immunotolerance in Regeneration, CRTD/DFG-Center for Regenerative Therapies Dresden, c/o Institute of Physiological Chemistry, MTZ, Technical University Dresden, Fiedlerstr. 42, 01307 Dresden, Germany
2These authors contributed equally to this work
Address correspondence to: Karsten Kretschmer, e-mail: karsten.kretschmer@crt-dresden.de
Manuscript submitted February 22, 2010; resubmitted April 21, 2010; accepted May 3, 2010.
Keywords: type 1 diabetes, NOD mouse, autoimmunity, immune regulation, regulatory T cell, FoxP3, dendritic cell, DEC-205, BDC2.5 mimotope, proinsulin
Abstract
Studies employing T cell receptor transgenic T cells have convincingly shown that selective delivery of non-self model antigens to DEC-205+ dendritic cells (DCs) in the steady-state can induce Foxp3-expressing CD4+CD25+ regulatory T (Treg) cells from conventional CD4+CD25-Foxp3- T cells. Although of considerable clinical interest, the concept of DC-targeted de novo generation of antigen-specific Treg cells has not yet been evaluated for self-antigens and self-reactive CD4+ T cells in the non-obese diabetic (NOD) mouse model of type 1 diabetes (T1D). Here, we show in proof-of-principle experiments that targeting a mimotope peptide to the endocytic receptor DEC-205 on DCs in NOD mice induces efficient conversion of pancreatic β-cell-reactive BDC2.5 CD4+ T cells into long-lived Foxp3+ Treg cells. Of note, conversion efficiency in normoglycemic and hyperglycemic mice with early diabetes onset was indistinguishable. While de novo generation of BDC2.5 Treg cells did not interfere with disease progression, anti-DEC-205-mediated targeting of whole proinsulin in prediabetic NOD mice substantially reduced the incidence of diabetes. These results suggest that promoting antigen-specific Treg cells in vivo might be a feasible approach towards cellular therapy in T1D.
Fulltext:
HTML
, PDF
(646KB)
This article has been cited by other articles:
|
Fluorochrome-based definition of naturally occurring Foxp3(+) regulatory T cells of intra- and extrathymic origin
Petzold C, Steinbronn N, Gereke M, Strasser RH, Sparwasser T, Bruder D, Geffers R, Schallenberg S, Kretschmer K
Eur J Immunol 2014. 44(12):3632-3645
|
|
|
Antigen-conjugated human IgE induces antigen-specific T cell tolerance in a humanized mouse model
Baravalle G, Greer AM, LaFlam TN, Shin JS
J Immunol 2014. 192(7):3280-3288
|
|
|
Targeted immunomodulation using antigen-conjugated nanoparticles
McCarthy DP, Hunter ZN, Chackerian B, Shea LD, Miller SD
Wiley Interdiscip Rev Nanomed Nanobiotechnol 2014. 6(3):298-315
|
|
|
Inducing immune tolerance: a focus on Type 1 diabetes mellitus
Xu D, Prasad S, Miller SD
Diabetes Manag (Lond) 2013. 3(5):415-426
|
|
|
Specialized role of migratory dendritic cells in peripheral tolerance induction
Idoyaga J, Fiorese C, Zbytnuik L, Lubkin A, Miller J, Malissen B, Mucida D, Merad M, Steinman RM
J Clin Invest 2013. 123(2):844-854
|
|
|
Total coumarins from Urtica dentata Hand prevent murine autoimmune diabetes via suppression of the TLR4-signaling pathways
Wang J, Lu J, Lan Y, Zhou H, Li W, Xiang M
J Ethnopharmacol 2013. 146(1):379-392
|
|
|
Dendritic cell subsets in type 1 diabetes: friend or foe?
Morel PA
Front Immunol 2013. 4:415
|
|
|
Foxp3(+) regulatory T cells in mouse models of type 1 diabetes
Petzold C, Riewaldt J, Watts D, Sparwasser T, Schallenberg S, Kretschmer K
J Diabetes Res 2013. 2013:940710
|
|
|
Engineering approaches to immunotherapy
Swartz MA, Hirosue S, Hubbell JA
Sci Transl Med 2012. 4(148):148rv9
|
|
|
Current and future immunomodulation strategies to restore tolerance in autoimmune diseases
Bluestone JA, Bour-Jordan H
Cold Spring Harb Perspect Biol 2012. 4(11):a007542
|
|
|
Vagaries of fluorochrome reporter gene expression in Foxp3+ regulatory T cells
Schallenberg S, Petzold C, Tsai PY, Sparwasser T, Kretschmer K
Plos One 2012. 7(8):e41971
|
|
|
Targeted Antigen Delivery to DEC-205(+) Dendritic Cells for Tolerogenic Vaccination
Petzold C, Schallenberg S, Stern JN, Kretschmer K
Rev Diabet Stud 2012. 9(4):305-318
|
|
|
Context and location dependence of adaptive Foxp3(+) regulatory T cell formation during immunopathological conditions
Heiber JF, Geiger TL
Cell Immunol 2012. 279(1):60-65
|
|
|
Antigen-specific therapeutic approaches in type 1 diabetes
Clemente-Casares X, Tsai S, Huang C, Santamaria P
Cold Spring Harb Perspect Med 2011. Epub
|
|
|
Functional alterations of proinflammatory monocytes by T regulatory cells: implications for the prevention and reversal of type 1 diabetes
Sia C, Hänninen A
Rev Diabet Stud 2010. 7(1):6-14
|
|
|